/Investor DB

Koch Disruptive Technologies — 2018 Investments

1 investments dated 2018 · listed companies and verified rows first · show all

Insightecinsightec.comin𝕏Jan 2018 · $150M

Insightec develops Exablate Neuro, an MRI-guided focused ultrasound platform that treats Essential Tremor and tremor-dominant Parkinson's Disease through an incision-free outpatient procedure.

HealthtechMedical DevicesTirat Carmel

Roni Karie(Vice President - Finance)Shirel Aroshase(Vice President - Human Resources)inEyal Zadicario(General Manager)inMenashe Frank(Vice President - Legal)inJun (Jim) Tao(Chief Operating Officer)inMaurice R. Ferre(Chairman and Chief Executive Officer)in

Co-investorsCatalio Capital Management, LPExigent CapitalGEOCJazzya InvestmentsKrillion VenturesPeregrine Ventures+7 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.